Bioton S.a.
BIO.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 2.25 | -4.00 | -1.36 |
| FCF Yield | 9.96% | -1.46% | 9.16% | -2.05% |
| EV / EBITDA | 9.14 | 11.99 | 6.09 | 10.21 |
| Quality | ||||
| ROIC | -1.08% | 0.67% | 0.84% | 0.64% |
| Gross Margin | 31.21% | 40.11% | 41.07% | 46.81% |
| Cash Conversion Ratio | -2.32 | 17.42 | 39.47 | 1.92 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.77% | 3.67% | 1.68% | -6.90% |
| Free Cash Flow Growth | 644.31% | -117.13% | 459.62% | -119.78% |
| Safety | ||||
| Net Debt / EBITDA | 1.52 | 2.07 | 1.15 | 2.24 |
| Interest Coverage | -0.70 | 1.81 | 2.71 | 3.16 |
| Efficiency | ||||
| Inventory Turnover | 1.33 | 0.92 | 1.25 | 0.68 |
| Cash Conversion Cycle | 224.63 | 357.96 | 268.98 | 513.65 |